Designed to enhance operational efficiency for the surgeon, the Conformis Hip System is the most advanced, patient-conforming hip replacement system available BILLERICA, Mass. , Nov. 07, 2019 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary

BILLERICA, Mass. , Oct. 30, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient-specific joint replacement implants designed to fit each patient's unique

BILLERICA, Mass. , Oct. 15, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, October 30, 2019 , at 4:30 p.m. Eastern Time to discuss its financial results for the third quarter ended September 30 , 2019.  The webcast will be live at:

BILLERICA, Mass. , Oct. 04, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell patient-specific joint replacement implants designed to fit each patient’s unique

Deal to Cover Patient-Specific Instrumentation Used in Knee Arthroplasty   BILLERICA, Mass. , Oct. 01, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell

BILLERICA, Mass. , July 31, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique

BILLERICA, Mass. , July 15, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique

BILLERICA, Mass. , July 15, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, July 31, 2019 , at 4:30 p.m. Eastern Time to discuss its financial results for the second quarter ended June 30 , 2019.  The webcast will be live at:

BILLERICA, Mass. , June 25, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique

BILLERICA, Mass. , May 01, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique

BILLERICA, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Conformis Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants customized to fit each patient’s unique anatomy, today

BILLERICA, Mass. , April 17, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, May 1, 2019 , at 4:30 p.m. Eastern Time to discuss its financial results for the first quarter ended March 31 , 2019.  The webcast will be live at:

Designed to enhance operational efficiency for the surgeon and improve patient outcomes, the Conformis Hip System is the most advanced, patient conforming hip replacement system available BILLERICA, Mass. , March 13, 2019 (GLOBE NEWSWIRE) -- Conformis Inc.

12-month average spending was $1,697 less for Medicare Fee for Service members who received customized implants compared to members who received standard off-the-shelf implants BILLERICA, Mass. , Feb. 18, 2019 (GLOBE NEWSWIRE) -- Conformis Inc. (NASDAQ:CFMS), a medical technology company that uses

BILLERICA, Mass. , Feb. 06, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique

BILLERICA, Mass. , Jan. 23, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, February 6, 2019 , at 4:30 p.m. Eastern Time to discuss its financial results for the fourth quarter and fiscal year ended December 31 , 2018.  The webcast

BILLERICA, Mass. and SAN FRANCISCO , Jan. 08, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants designed to fit each patient’s unique